Performance Improvement 2011-2012. Is an Evaluation of the National Cancer Institute's Office of Advocacy Relations Feasible and Warranted?


This study determined the overall feasibility of conducting a comprehensive process and outcome evaluation of the National Cancer Institute's Office of Advocacy Relations (OAR). OAR was created to strengthen the Institute's communications, collaborations, and relationships with national advocacy and voluntary organizations that work with consumer advocates, as well as scientific and professional societies concerned about cancer. The feasibility study used four data collection approaches: review of background materials and previous studies, review of existing OAR databases, review of relevant websites and e-publications, and interviews with current and former OAR staff.

The evaluators concluded that a comprehensive process and outcome evaluation was feasible and warranted. They determined that it was appropriate to assess OAR's internal staff and external advocacy community customers' utilization of and satisfaction with OAR services; and the nature, quality, and impact of relationships and collaborations resulting from OAR activities. They recommended and designed an evaluation consisting of three phases: develop and implement tracking systems, measure short-term outputs and outcomes, and measure intermediate and long-term outcomes.

Report Title: National Cancer Institute Office of Advocacy Relations Feasibility Study

Agency Sponsor: NIH, National Institutes of Health
Federal Contact: Rosanna Ng, 301-496-5367
Performer: The Madrillon Group, Inc.
Record ID: 9504 (Report issued November 16, 2010)

View full report


"PerformanceImprovement2011-2012.pdf" (pdf, 701.44Kb)

Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®